Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management
MZ Handler, PA Patel, R Kapila, Y Al-Qubati… - Journal of the American …, 2015 - Elsevier
The diagnosis of leishmaniasis can be challenging because it mimics both infectious and
malignant conditions. A misdiagnosis may lead to an unfavorable outcome. Using culture …
malignant conditions. A misdiagnosis may lead to an unfavorable outcome. Using culture …
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
Introduction Leishmaniasis is a major public health problem and the second most lethal
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral …
Parasites of the genus Leishmania are unusual unicellular microorganisms in that they are
characterized by the capability to subvert in their favor the immune response of mammalian …
characterized by the capability to subvert in their favor the immune response of mammalian …
Vaccine candidates against leishmania under current research
Introduction: The search for vaccines to prevent human leishmaniasis is an active field of
investigation aimed to prevent the devastating effects of this family of diseases on human …
investigation aimed to prevent the devastating effects of this family of diseases on human …
Leishmania Hijacks Myeloid Cells for Immune Escape
Protozoan parasites of the Leishmania genus are the causative agents of leishmaniasis, a
group of neglected tropical diseases whose clinical manifestations vary depending on the …
group of neglected tropical diseases whose clinical manifestations vary depending on the …
[HTML][HTML] Advances in Leishmania Vaccines: Current Development and Future Prospects
Leishmaniasis is a neglected tropical disease caused by parasites of the genus Leishmania.
As approved human vaccines are not available, treatment and prevention rely heavily on …
As approved human vaccines are not available, treatment and prevention rely heavily on …
Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities
JA Mendoza-Roldan, MS Latrofa, R Iatta… - Parasites & …, 2021 - Springer
Background Leishmania tarentolae is a protozoan isolated from geckoes (Tarentola
annularis, Tarentola mauritanica), which is considered non-pathogenic and is transmitted by …
annularis, Tarentola mauritanica), which is considered non-pathogenic and is transmitted by …
Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection
Progress in tuberculosis vaccine development is hampered by an incomplete understanding
of the immune mechanisms that protect against infection with Mycobacterium tuberculosis …
of the immune mechanisms that protect against infection with Mycobacterium tuberculosis …
Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines
A Banerjee, P Bhattacharya, AB Joshi, N Ismail… - Cellular …, 2016 - Elsevier
The clinical outcome of Leishmania pathogenesis ranges from active skin lesions to fatal
visceral dissemination and severely impaired T cell immunity. It is well established that a …
visceral dissemination and severely impaired T cell immunity. It is well established that a …
Live attenuated Leishmania donovani centrin gene–deleted parasites induce IL-23–dependent IL-17–protective immune response against visceral leishmaniasis in a …
No vaccine exists against visceral leishmaniasis. To develop effective vaccines, we have
previously reported protective role of live attenuated centrin gene–deleted Leishmania …
previously reported protective role of live attenuated centrin gene–deleted Leishmania …